Haemonetics Corporation Business Combination, Contingent Consideration, Liability, Current
Haemonetics Corporation (HAE) had Business Combination, Contingent Consideration, Liability, Current of $17.60 million as of 2026-03-28, per its 10-K filed 2026-05-20.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent · last filed 2026-05-20
- 2026-03-28: Business Combination, Contingent Consideration, Liability, Current $17.60M.
- 2025-03-29: Business Combination, Contingent Consideration, Liability, Current $2.28M.
- 2023-04-01: Business Combination, Contingent Consideration, Liability, Current $863.00K.
- 2022-04-02: Business Combination, Contingent Consideration, Liability, Current $31.18M.
| Period end | Business Combination, Contingent Consideration, Liability, Current |
|---|---|
| 2026-03-28 | $17.60M 10-K · filed 2026-05-20 |
| 2025-03-29 | $2.28M 10-K · filed 2026-05-20 |
| 2023-04-01 | $863.00K 10-K · filed 2023-05-22 |
| 2022-04-02 | $31.18M 10-K · filed 2023-05-22 |
| 2021-04-03 | $20.94M 10-K · filed 2022-05-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |